We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$94B
AUM Growth
+$5.35B
Cap. Flow
-$10.2B
Cap. Flow %
-10.87%
Top 10 Hldgs %
22.25%
Holding
2,551
New
400
Increased
743
Reduced
692
Closed
262

Sector Composition

Rank Sector Weight
1 Technology 20.36%
2 Healthcare 14.2%
3 Financials 13.3%
4 Industrials 9.5%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEU icon
601
NewMarket
NEU
$8.11B
$4.51M ﹤0.01%
13,173
+11,826
+878% +$4.08M
MLM icon
602
Martin Marietta Materials
MLM
$33.2B
$4.5M ﹤0.01%
10,211
-13,204
-56% -$5.35M
EMR icon
603
Emerson Electric
EMR
$90.6B
$4.45M ﹤0.01%
47,886
-41,481
-46% -$3.91M
AMT icon
604
American Tower
AMT
$78.3B
$4.42M ﹤0.01%
15,129
+1,147
+8% +$313K
MOH icon
605
Molina Healthcare
MOH
$10.2B
$4.41M ﹤0.01%
13,853
+10,244
+284% +$3.05M
IWM icon
606
iShares Russell 2000 ETF
IWM
$82.5B
$4.39M ﹤0.01%
19,739
DTE icon
607
DTE Energy
DTE
$29.1B
$4.38M ﹤0.01%
36,628
+27,590
+305% +$3.15M
VCIT icon
608
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
0
CHE icon
609
Chemed
CHE
$7.14B
$4.36M ﹤0.01%
8,248
-8,173
-50% -$3.92M
CPRT icon
610
Copart
CPRT
$26.8B
$4.3M ﹤0.01%
113,584
-48,568
-30% -$1.8M
QRVO icon
611
Qorvo
QRVO
$8.4B
$4.3M ﹤0.01%
27,479
-7,962
-22% -$1.27M
LQD icon
612
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
0
URBN icon
613
Urban Outfitters
URBN
$6.67B
$4.28M ﹤0.01%
145,753
+28,613
+24% +$907K
ASGI
614
abrdn Global Infrastructure Income Fund
ASGI
$758M
$4.26M ﹤0.01%
207,761
GM icon
615
General Motors
GM
$78.2B
$4.25M ﹤0.01%
72,578
+5,116
+8% +$299K
BEAM icon
616
Beam Therapeutics
BEAM
$2.8B
$4.23M ﹤0.01%
53,128
+27,322
+106% +$2.34M
ZLAB icon
617
Zai Lab
ZLAB
$2.07B
$4.17M ﹤0.01%
66,339
-31,101
-32% -$2.64M
ABCL icon
618
AbCellera Biologics
ABCL
$1.81B
$4.16M ﹤0.01%
290,746
+149,738
+106% +$2.27M
NBIX icon
619
Neurocrine Biosciences
NBIX
$16.4B
$4.13M ﹤0.01%
48,508
+14,394
+42% +$1.32M
ECPG icon
620
Encore Capital Group
ECPG
$1.99B
$4.13M ﹤0.01%
+66,454
New +$3.74M
IEFA icon
621
iShares Core MSCI EAFE ETF
IEFA
$194B
$4.1M ﹤0.01%
54,959
+10,181
+23% +$765K
POOL icon
622
Pool Corp
POOL
$7.51B
$4.09M ﹤0.01%
7,237
+5,596
+341% +$2.93M
LAUR icon
623
Laureate Education
LAUR
$5.24B
$4.06M ﹤0.01%
+331,869
New +$4.35M
SYF icon
624
Synchrony
SYF
$25.8B
$4.04M ﹤0.01%
87,059
+18,644
+27% +$896K
LOPE icon
625
Grand Canyon Education
LOPE
$3.92B
$4.03M ﹤0.01%
47,010
+39,526
+528% +$3.26M

Similar funds

Lazard Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Lazard Asset Management held 2,551 positions worth $94B, up 6% from $88.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lazard Asset Management withdrew a net $10.2B in Q4 2021, closing 262 positions and reducing 692 holdings. Its most notable exit was Innospec, an estimated $21M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Asset Management opened a new position in Wells Fargo 7.5% Non Cumv Perp Conv worth $922K.

  • Lazard Asset Management's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 61,920 shares worth $922K.
  • Lazard Asset Management added most to Pinnacle West Capital in Q4 2021, an estimated $455M increase.
  • Lazard Asset Management's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $545M.
  • Lazard Asset Management fully exited Innospec in Q4 2021, selling an estimated $21M.
  • Lazard Asset Management's ten largest holdings make up 22% of its $94B portfolio in Q4 2021.
  • Lazard Asset Management opened 400 new positions and closed 262 in Q4 2021.
  • Lazard Asset Management's portfolio value rose 6% quarter-over-quarter to $94B.

Based on Lazard Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.